New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer
Ji-Chun Zhou,1 Ju-Feng Guo,1,2 Rong-Yue Teng,1 Qin-Chuan Wang,1 Ji Wang,1 Qun Wei,1,3 Zi-Duo Li,1,4 Jian-Guo Shen,1 Lin-Bo Wang1,5 1Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 2Department of Surgical Oncology, Hangzhou First People’s...
Main Authors: | Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-08-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/new-utility-of-an-old-marker-serum-low-density-lipoprotein-predicts-hi-peer-reviewed-article-OTT |
Similar Items
-
The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
by: Juan Sun, et al.
Published: (2021-04-01) -
Is Pathologic Complete Response the Surrogate in Primary Gastric Angiosarcoma Undergoing Doxorubicin-Based Neoadjuvant Chemotherapy? A Case Report
by: Zheng CH, et al.
Published: (2020-12-01) -
Overall Survival Results with Surgical Treatment After Neoadjuvant Chemotherapy in Local Invasive Gastric Cancers
by: Gökhan Ertuğrul
Published: (2019-04-01) -
Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
by: Qing Hu, et al.
Published: (2021-06-01) -
Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer
by: Lin Jiang, et al.
Published: (2021-02-01)